Protective effect of ginsenoside Rg1 on attenuating anti-GBM glomerular nephritis by activating NRF2 signalling

References

• Wieliczko M, Dylewska M.iga nephropathy-prognostic factors and treatment. Wiad Lek. 2016;69:707–710.
   PubMedGoogle Scholar
• Krebs CF, Panzer U. Plasticity and heterogeneity of th17 in immune-mediated kidney diseases. J Autoimmun. 2018;87:61–68.
   PubMed Web of Science ®Google Scholar
• Sato M, Takei T, Moriyama T, et al. Long-term outcomes of initial therapy for idiopathic membranous nephropathy. Clin Exp Nephrol. 2017;21:842–851.
   PubMed Web of Science ®Google Scholar
• Pfister F, Buttner-Herold M, Amann K. (immuno-)pathology of drug side effects in the kidney. Pathologe. 2018;39:576–582.
   PubMed Web of Science ®Google Scholar
• Jefferson JA. Complications of immunosuppression in glomerular disease. Clin J Am Soc Nephrol. 2018;13:1264–1275.
   PubMed Web of Science ®Google Scholar
• Nagy J, Sagi B, Mate J, et al. considerations on the treatment of IGA nephropathy on the basis of the results of the latest studies (stop-igan, testing, nefigan). Orv Hetil. 2017;158:1946–1952.
   PubMed Web of Science ®Google Scholar
• Arranz O, Ara J, Rodriguez R, et al. rapid-detection GBM-ANCA Elisa. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis. Nefrologia 2001;21:349–354.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Yamada H, Ito M. antinephritic effect of md-805 [(2r, 4r)-4-methyl-[n2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-l-arginyl]-2-piperidine-carboxylic acid monohydrate], a new antithrombin agent, on crescentic-type anti-GBM nephritis in rats. Nihon Jinzo Gakkai Shi. 1984;26:463–473.
   PubMedGoogle Scholar
• Takaki T, Ohno N, Saitoh S, et al. Podocyte penetration of the glomerular basement membrane to contact on the mesangial cell at the lesion of mesangial interposition in lupus nephritis: a three-dimensional analysis by serial block-face scanning electron microscopy. Clin Exp Nephrol. 2019;23:773.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Jeon JN, Jang MG, et al. Ginsenoside profiles and related gene expression during foliation in panax ginseng meyer. J Ginseng Res. 2014;38:66–72.
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Dong E. Role of ginsenoside-rd in cisplatin-induced renal injury: Special reference to DNA fragmentation. Nephron 2001;89:433–438.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang F, Luo Y. Ginsenoside rg1 protects against sepsis-associated encephalopathy through beclin 1-independent autophagy in mice. J Surg Res. 2017;207:181–189.
   PubMed Web of Science ®Google Scholar
• Zu G, Guo J, Che N, et al. Protective effects of ginsenoside rg1 on intestinal ischemia/reperfusion injury-induced oxidative stress and apoptosis via activation of the wnt/beta-catenin pathway. Sci Rep. 2016;6:38480.
   PubMed Web of Science ®Google Scholar
• El Nakeeb N, Saleh SA, Massoud YM, et al. Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among egyptian patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2017;1:112–119.
   Google Scholar
• McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12:1162–1172.
   PubMed Web of Science ®Google Scholar
• Westhorpe CLV, Norman MU, Hall P, et al. Effector CD4(+) t cells recognize intravascular antigen presented by patrolling monocytes. Nat Commun. 2018;9:747.
   PubMed Web of Science ®Google Scholar
• Woollard KJ, Pusey CD. The heterogeneous mononuclear phagocyte system of the kidney. Kidney Int. 2014;85:1011–1014.
   PubMed Web of Science ®Google Scholar
• Hou W, Huang G, Cao X, et al. Suppression of experimental autoimmune glomerulonephritis by tryptophan. J Nephrol. 2014;27:19–28.
   PubMed Web of Science ®Google Scholar
• Wang W, Chen N. Treatment of progressive iga nephropathy: an update. Contrib Nephrol. 2013;181:75–83.
   PubMed Web of Science ®Google Scholar
• Wofsy D, Hillson JL, Diamond B. Comparison of alternative primary outcome measures for use in lupus nephritis clinical trials. Arthritis Rheum. 2013;65:1586–1591.
   PubMed Web of Science ®Google Scholar
• Wang YJ, He LQ, Sun W, et al. Optimized project of traditional chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial. J Ethnopharmacol. 2012;139:757–764.
   PubMed Web of Science ®Google Scholar
• Xie XS, Liu HC, Wang FP, et al. Ginsenoside rg1 modulation on thrombospondin-1 and vascular endothelial growth factor expression in early renal fibrogenesis in unilateral obstruction. Phytother Res. 2010;24:1581–1587.
   PubMed Web of Science ®Google Scholar
• Fan Y, Xia J, Jia D, et al. Mechanism of ginsenoside rg1 renal protection in a mouse model of d-galactose-induced subacute damage. Pharm Biol. 2016;54:1815–1821.
   PubMed Web of Science ®Google Scholar
• Mao N, Cheng Y, Shi XL, et al. Ginsenoside rg1 protects mouse podocytes from aldosterone-induced injury in vitro. Acta Pharmacol Sin. 2014;35:513–522.
   PubMed Web of Science ®Google Scholar
• Han Y, Ma FY, Tesch GH, et al. C-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-gbm glomerulonephritis in the rat. Lab Invest. 2011;91:978–991.
   PubMed Web of Science ®Google Scholar
• Ebihara S, Tajima H, Ono M. Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis. Arthritis Res Ther. 2016;18:139.
   PubMed Web of Science ®Google Scholar
• Im SR, Im SW, Chung HY, et al. Cell- and nuclear-penetrating anti-dsdna autoantibodies have multiple arginines in cdr3 of vh and increase cellular level of perk and bcl-2 in mesangial cells. Mol Immunol. 2015;67:377–387.
   PubMed Web of Science ®Google Scholar
• Wang C, Blough E, Arvapalli R, et al. Acetaminophen attenuates glomerulosclerosis in obese zucker rats via reactive oxygen species/p38mapk signalling pathways. Free Radic Biol Med. 2015;81:47–57.
   PubMed Web of Science ®Google Scholar